Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS), which impacts 1 in 8, or more than 170 million women worldwide.
In our Pathways to Care for PCOS-PMOS in Alberta, assessing cardiometabolic risk at diagnosis is key to better care for those with PMOS (see below).
The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), has just been published in The Lancet and is being announced currently at the European Congress of Endocrinology Conference May 2026.
Here are some resources and videos for you to share with your networks – https://bit.ly/3V85nPJ. There are patient and health professionals resources that have been translated in English, Arabic, Persian, Mandarin, German, Spanish, Portuguese, French, German and other languages.
For more information: https://www.mchri.org.au/guidelines-resources/community/pcos-resources-2
PCOS Together's mission is to improve our understanding of health outcomes and health care in women with and without PCOS in Canada. The focus is on cardiometabolic risk, diabetes and cardiovascular disease and improving health care in those with PCOS.
PCOS Together is a research program aimed at understanding the health status and improving the health and health care of women with PCOS. To do this we are trying to understand the health risks and long term health outcomes in women with PCOS. We have found that women with PCOS in Alberta are at 2 and 3 fold higher risk for developing diabetes and cardiovascular disease. We are establishing methods to detect early disease risk in women with PCOS. We are also undertaking clinical interventions to treat high-risk women with PCOS in the prevention of diabetes and cardiovascular disease.
Heart health in women with and without PCOS
(RECRUITING NOW-Click Here to Learn More)
Understanding health care and nutrition services in women with PCOS
Fish oil-metformin improves blood lipids in high-risk women with PCOS
Eating habits and disordered eating patterns in those with and without PCOS
Tracking early cardiovascular disease progression in young women with and without PCOS
Click Here to Register & Pay: https://raceroster.com/registration/e04e364d-c3cf-49cd-ba92-a3ac133e3af8/entry?team=950834
PCOS Patient Partner Featured at Ceremony for Largest Gift in UofA History for Women’s and Children’s Health
Sarah Chambers knows this feeling too well. After the Edmonton resident was diagnosed with polycystic ovary syndrome (PCOS), her family doctor didn’t have much medical advice to share beyond what would be useful if she were trying to have a baby.
WCHRI researcher Donna Vine, however, has upended the misconception that PCOS is mainly a reproductive condition. After finding that women with PCOS are three times more likely to develop diabetes and cardiovascular disease, Vine is now operating clinical trials with patients from the Lois Hole Hospital for Women to establish methods of detecting and treating these diseases.
Learn more about how WCHRI is transforming lives to help women and children thrive
Award for 2025 Top Fundraising Team: Run For Women
AE-PCOS (2024) Annual Meeting: Verity PCOS UK Poster Award for Best Patient Engagement for the Pathways to Care and our Heart Health studies
PCOS Together on Global News, Health Matters on Monday, May 31, 2021, 6pm